Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 274

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 274
---
54,931 | ) |
| TOTAL SHAREHOLDERS’ DEFICIT                                                                                      |     |   |      (164,859 | ) |     |   |   (19,931 | ) |
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT                                                                      |     | $ |       426,139 |   |     | $ |   191,055 |   |

____________ (1)Includes an aggregate of up to 1,285,714 ordinary shares subject to surrender and forfeiture if the over -allotmentoption is not exercised in full by the underwriters (Note 5). (2)On November 6, 2024, the Sponsor surrendered and forfeited 12,503,968 ordinary shares to the Company for no consideration, following which the Sponsor holds 9,857,143 ordinary shares (the “Founder Shares”). All share and per share data has been retrospectively presented. The accompanying notes are an integral part of these financial statements.

F-3

DRUGS MADE IN AMERICA ACQUISITION CORP.
STATEMENTS OF OPERATIONS

|                                                                       |     |   |       For The 
   Period From 
  May 23, 2024 
   (Inception) 
       Through 
 September 30, 
          2024 
   (Unaudited) |   |     |   |       For The 
   Period From 
  May 23, 2024 
   (Inception) 
       Through 
 June 30, 2024 
     (Audited) |   |
|:----------------------------------------------------------------------|:----|:--|--------------:|:--|:----|:--|--------------:|:--|
| General and administrative costs                                      |     | $ |       199,859 |   |     | $ |        54,931 |   |
| Net loss                                                              |     | $ |      (199,859 | ) |     | $ |       (54,931 | ) |
| Weighted average ordinary shares outstanding, basic and diluted(1)(2) |     |   |     8,571,429 |   |     |   |     8,571,429 |   |
| Basic and diluted net loss per ordinary share                         |     | $ |         (0.02 | ) |     | $ |         (0.01 | ) |

____________ (1)Excludes an aggregate of up to 1,285,714 ordinary